{"id":"92b2de7e-1b71-444b-81d1-7b560c8913c6","kind":"news","code":"92b2de7e-1b71-444b-81d1-7b560c8913c6","name":"Aureka Biotechnologies raises tens of millions of USD in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Aureka Biotechnologies完成数千万美元A轮融资","eventDate":"2025-11-10T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-13T16:57:22.821Z","englishUpdatedAt":"2026-10-15T17:19:59.743Z","reviewedAt":"2026-10-15T17:19:59.743Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"84a2442c0dfa60900e3229f90f9e51cbbad2e0c9ea0eeff3049c3598a94b0821","companyId":"45d3d734-4612-4acd-93a4-8687ab7e94ca","foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"884503b6-b4e3-4a09-a195-674d61f07198","kind":"institutions","code":"UB-I1572","name":"Agentic Ventures","nameBasis":"original-brand","summary":"An early-stage venture capital firm focused on AI agents.","description":"An early-stage venture capital firm focused on AI agents.","country":"Singapore","category":null,"originalName":"Agentic Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:17.915Z","englishUpdatedAt":"2026-10-20T18:26:56.957Z","reviewedAt":"2026-10-20T18:26:56.957Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"e4d39e0570629189eeaa60065b44b39a8416de7ecc4cb91a2292eff2e306dbe6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/agentic-ventures"},{"id":"45d3d734-4612-4acd-93a4-8687ab7e94ca","kind":"companies","code":"UB-C5576","name":"Aureka Biotechnologies","nameBasis":"source-english","summary":"Antibody drug discovery driven by generative AI and digital biology","description":"","country":null,"category":null,"originalName":"Aureka Biotechnologies","eventDate":null,"website":"https://www.aurekabio.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:23:30.014Z","reviewedAt":"2026-10-20T18:23:30.014Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"3bd42e5b778768ce4e8c1f0761b984ee7ceb9b5700c511566f259d9de0713575","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/aureka-biotechnologies"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"Niuerli Capital","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/niuerli-capital"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"},{"id":"ff7d41a5-b7cd-44a1-a23b-bc9e082639a4","kind":"institutions","code":"UB-I016","name":"Wuyuan Capital","nameBasis":"transliterated","summary":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","description":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","country":null,"category":null,"originalName":"五源资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.242Z","englishUpdatedAt":"2026-10-15T21:43:23.741Z","reviewedAt":"2026-10-15T21:43:23.741Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7368ba44c3815996c52f9d8d28ae59336c59aa7539208a5ef5949f6cc0f793e0","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/wuyuan-capital"}],"path":"/news/92b2de7e-1b71-444b-81d1-7b560c8913c6","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Aureka Biotechnologies","path":"/companies/aureka-biotechnologies"}},"canonical":"https://uniquebase.ai/news/92b2de7e-1b71-444b-81d1-7b560c8913c6"}